Publications by authors named "M Lariviere"
Article Synopsis
- Proton therapy (PT) is a treatment that can be helpful for kids with Hodgkin lymphoma, especially for areas below the diaphragm (infradiaphragmatic regions).
- A study looked at 21 patients who received PT from 2011 to 2022, showing that it had low side effects, and most patients were healthy at the end of the study.
- PT was found to be better than regular radiation (photon therapy) because it caused less harm to important organs like the stomach and kidneys.
Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 (CART-19) represents a significant advance in the treatment of patients with relapsed or refractory CD19+ B-cell lymphomas. However, a significant portion of patients either relapse or fail to respond. Moreover, many patients have symptomatic disease, requiring bridging radiation therapy (RT) during the period of CAR T-cell manufacturing.
View Article and Find Full Text PDFPurpose: To assess whether a radiation therapy (RT) dose affects response in bulky tumors in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
Methods And Materials: Data from patients with r/r DLBCL treated with salvage- or palliative-intent RT (2008-2020) at a single institution were examined. Index lesion size ≥7.
Purpose: The purpose of this study was to evaluate the feasibility and safety of dose-escalated proton beam therapy for treating chordomas and chondrosarcomas of the skull base and spine. Methods: A prospective cohort of 54 patients (42 with chordomas and 12 with chondrosarcomas) was enrolled between 2010 and 2018. The primary endpoints were feasibility and <20% rate of acute grade ≥3 toxicity, and secondary endpoints included cancer-specific outcomes and toxicities.
View Article and Find Full Text PDF